Hims - Latest News and Information
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Hims is a Canadian online health brand offering personalized medical consultations, prescriptions, and home delivery for men’s health needs. The service provides telehealth access to treatments for erectile dysfunction, weight loss, and acne, with nationwide shipping and discreet packaging. They emphasize at-home care with licensed providers and ongoing support, aiming to bring healthcare into the home. The Canada site highlights 2.4 million subscribers and telehealth-enabled care across the country.
Telehealth Provider Hims Goes After Novo's Weight Loss Pill with Compounded Version
Hims Adds Grail's Cancer Test Amid Questions About Widespread Use
Qualcomm Downgraded, Rivian Upgraded: Wall Street's Top Analyst Calls
3 Trends Shaping the GLP-1 Landscape
FDA Chief Makary Takes Aim at Hims' Compounded Wegovy Pill Plans
Data Breaches Hit Hims & Hers and TriZetto, Exposing Millions of Patient Records
Grail Multi-Cancer Test Taps Into Hims & Hers Network
Hims Reports 2025 Earnings, Shares Details on GLP-1 Pill Decisions
The Peptide Boom Is Getting Out of Hand
GLP-1s and the Super Bowl
Hims & Hers Plans to Acquire Eucalyptus for $1.15B
Telehealth Giant Hims & Hers Says Its Customer Support System Was Hacked
Hims & Hers Stock Crashes After FDA Announces Plans to Take 'Decisive Steps' Against GLP-1 Compounds
Post-Hoc Live: Analyzing the Novo Vs. Hims GLP-1 Showdown
From Svedka to Anthropic, Brands Make Bold Plays with AI in Super Bowl Ads
Hims & Hers Copies Novo Nordisk's New Wegovy Pill
Novo Nordisk Signs Deal with Hims & Hers
Blackbird-Backed Telehealth Startup Eucalyptus Sells for $1.6 Billion to US Listed Rival
Eli Lilly Finds Impurity in Compounded Tirzepatide
